Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis (Q47421281)

16 January 2018

title

Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis (English)

1 reference

16 January 2018

1 reference

10

Jürgen Schölmerich

1 reference

16 January 2018

Thomas Rabenstein

1

1 reference

16 January 2018

Bernhard Fischer

2

1 reference

16 January 2018

Volkmar Wiessner

3

1 reference

16 January 2018

Harald Schmidt

4

1 reference

16 January 2018

Martin Radespiel-Tröger

5

1 reference

16 January 2018

Jürgen Hochberger

6

1 reference

16 January 2018

Steffen Mühldorfer

7

1 reference

16 January 2018

Gerhard Nusko

8

1 reference

16 January 2018

Helmut Messmann

9

1 reference

16 January 2018

Hans-Joachim Schulz

11

1 reference

16 January 2018

Herbert Schönekäs

12

1 reference

16 January 2018

Eckhart Gustav Hahn

13

1 reference

16 January 2018

Hans Thomas Schneider

14

1 reference

16 January 2018

language of work or name

English

0 references

publication date

1 May 2004

1 reference

16 January 2018

Gastrointestinal Endoscopy

published in

1 reference

16 January 2018

volume

59

1 reference

16 January 2018

issue

6

1 reference

16 January 2018

page(s)

606-613

1 reference

16 January 2018

Complications of endoscopic biliary sphincterotomy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Complications of diagnostic and therapeutic ERCP: a prospective multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Risk factors for post-ERCP pancreatitis: a prospective, multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Analysis of the risk factors associated with endoscopic sphincterotomy techniques: preliminary results of a prospective study, with emphasis on the reduced risk of acute pancreatitis with low-dose anticoagulation treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Endoscopic sphincterotomy complications and their management: an attempt at consensus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

ERCP- and endoscopic sphincterotomy-induced pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Complications of endoscopic sphincterotomy and their prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Diagnosis and prevention of post-ERCP pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Prevention of post-ERCP pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Post-ERCP pancreatitis: new momentum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leucocytes to vascular endothelium in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Heparin in inflammation: potential therapeutic applications beyond anticoagulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Safety and efficacy of pancreatic sphincterotomy in chronic pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Tests for Linear Trends in Proportions and Frequencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900159-2

10.1016/S0016-5107(04)00159-2

7 January 2021

Identifiers

DOI

1 reference

16 January 2018

1 reference

16 January 2018